Li, Junxian
Li, Chenyang
Feng, Ziwei
Liu, Luyang
Zhang, Liwen
Kang, Wenjuan
Liu, Ya
Ma, Baoshan
Li, Haixin
Huang, Yubei
Zheng, Hong
Song, Fangfang
Song, Fengju http://orcid.org/0000-0003-1542-0828
Chen, Kexin
Funding for this research was provided by:
National Key Research and Development Program of China (2018YFC1315600)
National Natural Science Foundation of China (81974439, 81974488)
Article History
Received: 7 December 2021
Accepted: 31 March 2022
First Online: 25 April 2022
Declarations
:
: The authors declare that they have no competing interests.
: The investigators in TBCCC obtained informed consent from each breast cancer patient and participants or their guardians. The current study was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments and it was approved by the research ethics board of the Tianjin Medical University Cancer Institute and Hospital.